Jiangsu Recbio Technology Balance Sheet Health
Financial Health criteria checks 5/6
Jiangsu Recbio Technology has a total shareholder equity of CN¥835.8M and total debt of CN¥681.3M, which brings its debt-to-equity ratio to 81.5%. Its total assets and total liabilities are CN¥2.1B and CN¥1.2B respectively.
Key information
81.5%
Debt to equity ratio
CN¥681.32m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥531.30m |
| Equity | CN¥835.76m |
| Total liabilities | CN¥1.22b |
| Total assets | CN¥2.06b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: G93's short term assets (CN¥795.4M) exceed its short term liabilities (CN¥681.6M).
Long Term Liabilities: G93's short term assets (CN¥795.4M) exceed its long term liabilities (CN¥541.3M).
Debt to Equity History and Analysis
Debt Level: G93's net debt to equity ratio (17.9%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if G93's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: G93 has sufficient cash runway for 9 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: G93 is forecast to have sufficient cash runway for 5 months based on free cash flow estimates, but has since raised additional capital.